Lly stock price target.

Eli Lilly Company Info. Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology ...

Lly stock price target. Things To Know About Lly stock price target.

The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry. There are 17 Sectors, 60 different M Industries, and 265 X ...24 Wall Street analysts have set twelve-month price targets for Eli Lilly and Company in the last year. Their average twelve-month price target is $557.00, suggesting a possible downside of 7.3%. Morgan Stanley has the highest price target set, predicting LLY will reach $722.00 in the next twelve months. Societe Generale has the lowest price ...15 Mar 2021 ... Eli Lilly And Co (LLY) stock has risen 46.85% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.Headquartered in Indianapolis, Indiana, Eli Lilly and Company (NYSE:LLY) is a pharmaceuticals company. On January 27, 2023, Eli Lilly and Company (NYSE:LLY) stock closed at $342.10 per share. One ...

Echoing similar sentiments, Bansal increased Eli Lilly’s price target to $650 from $615 and reiterated a Buy on October 9. The analyst sees a massive market opportunity for its obesity-related drug.

14 analysts have issued 1-year target prices for Citigroup's stock. Their C share price targets range from $43.00 to $85.00. On average, they anticipate the company's share price to reach $51.66 in the next twelve months. This suggests a possible upside of 9.4% from the stock's current price.

Eli Lilly and Company Stock Price, News & Analysis (NYSE:LLY) $591.86 +0.26 (+0.04%) (As of 04:31 PM ET) Compare Today's Range $584.44 $594.54 50-Day Range $525.10 …Jul 21, 2023 · On July 21, 2023, Eli Lilly and Co (LLY) stock showed promising performance based on the information provided by CNN Money. The 23 analysts offering 12-month price forecasts for LLY had a median target of $490.00, with a high estimate of $565.00 and a low estimate of $300.00. In terms of financial performance, LLY reported earnings per share of ... May 13, 2023 · The path to $1 trillion. Today, Eli Lilly's market cap is a little north of $410 billion, which puts it among the top handful of big pharma companies. That means it'd need to grow by nearly 166% ... Find real-time NVO - Novo Nordisk A/S stock quotes, company profile, news and forecasts from CNN Business.I still cannot get close to a target price >$300 - Lilly stock currently trades at $335. I am mystified and making the bear case once again. ... The current LLY share prices factor in a positive ...

See Eli Lilly and Company (LLY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Institutional investors own 81.38% of the company's stock. Analysts Set New Price Targets. Several brokerages have issued reports on LLY. Bank of America upped their price target on shares of Eli Lilly and Company from $600.00 to $700.00 in a research report on Friday, October 6th. Barclays upped their price target on shares of Eli Lilly and ...

What is the Target Price for LLY Stock? ... After a 75.79% rally in its share price over the past year, the average LLY price target of $645.72 per share implies 6.31% upside potential.Responding to an email query, Cramer mentioned a new 12-month price target of $600 for Eli Lilly. Despite the promising outlook, the rapid ascent of Eli Lilly’s stock has led to caution.Eli Lilly And Co Follow Share $584.04 After Hours: $584.53 (0.084%) +0.49 Closed: Dec 1, 6:20:26 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Novo Nordisk A/S …24 Wall Street analysts have set twelve-month price targets for Eli Lilly and Company in the last year. Their average twelve-month price target is $557.00, suggesting a possible downside of 7.3%. Morgan Stanley has the highest price target set, predicting LLY will reach $722.00 in the next twelve months. Societe Generale has the lowest price ...29 Jul 2023 ... ... LLY share price made a bullish graph. Source: Price Target of LLY Stock by TradingView. The 1-year price target set by the analysts is at ...See Eli Lilly and Company (LLY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Aug 17, 2023 · Responding to an email query, Cramer mentioned a new 12-month price target of $600 for Eli Lilly. Despite the promising outlook, the rapid ascent of Eli Lilly’s stock has led to caution. Average 611.01 (+2.63% Upside) High | 722.00. Average | 611.01. Low | 368.00. Past 12 Months. 12-Month Forecast. 200 300 400 500 600 700 800. Data Based on a Poll of 30 …Eli Lilly is a leading healthcare business that went on a tear last year in the stock market. Despite the company's growth slowdown in the past year, the stock gained ~32% while tToday, Wells Fargo analyst Mohit Bansal upgraded the stock’s rating to a Buy from a Hold, with a price target of $375. Overall, the consensus 12-month price target of top analysts suggests an ...But Lilly's tirzepatide also targets a second hormone called GIP to improve the effects. ... LLY stock analysts also expect Alzheimer's drug donanemab to bring in $3 million this year before ...Find real-time LOW - Lowe's Companies Inc stock quotes, company profile, news and forecasts from CNN Business.

Eli Lilly is a dividend paying company with a current yield of 0.75%. Upcoming dividend of US$1.13 per share at 0.8% yield. Upcoming dividend of US$1.13 per share at 1.0% yield. Eli Lilly and Company Declares Third-Quarter 2023 Dividend, Payable on September 8, 2023. Eli Lilly and Company (NYSE:LLY) acquired unknown minority …11/22/23-8:06AM EST Benzinga. 11/22/23-3:35AM EST MarketWatch. LLY: Eli Lilly - Price and Consensus Chart. Get the latest Price and Consensus Chart for Eli Lilly from Zacks Investment Research.

With strong results and well-positioned for future growth, here’s what we think of Eli Lilly’s stock. Damien Conover, CFA. Nov 7, 2023. Eli Lilly LLY reported earnings on Nov 2. With Lilly ...The consensus view among 15 analysts who cover Moderna is to “buy” the stock. The median price target on the shares is 54% higher than ... LLY stock has gained 35% in the last 12 months and is ...Research Eli Lilly's (NYSE:LLY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Price target increased by 7.2% to US$415 May 12. Eli Lilly and Company Discloses First-in-Class, Interim Phase 2 Data in Pediatric Patients and New Analysis from Phase 3 Program in …Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 6, 2023 · Turning to Wall Street, analysts have a Strong Buy consensus rating on LLY stock based on 16 Buys, one Hold, and zero Sells assigned in the past three months, as indicated by the graphic above. Furthermore, the average price target of $599.56 per share implies 7.10% upside potential. Nov 14, 2023 · What is the Target Price for LLY Stock? ... After a 75.79% rally in its share price over the past year, the average LLY price target of $645.72 per share implies 6.31% upside potential. Eli Lilly and Company (LLY) stock forecast and price target. Find the latest Eli Lilly and Company LLY analyst stock forecast, price target, and recommendation trends with in-depth analysis from ... Dec 1, 2023 · The consensus rating for Eli Lilly and Company (LLY) is Moderate Buy based on 21 analyst ratings, with a high price target of $710.00 and a low price target of $278.00. The stock has a predicted upside of 13.01% based on the 12-month forecast. See the latest ratings, news, and analysis for LLY on MarketBeat. DJIA S&P 500 GLOBAL DOW NASDAQ Health Care/Life Sciences Compare to Open 591.70 Prior Close 591.04 (11/30/23) 1 Day LLY -1.18% DJIA 0.82% S&P 500 0.59% Health Care/Life Sciences 0.38% Overview...What is the target price for Eli Lilly (LLY) stock? A. The latest price target for Eli Lilly ( NYSE: LLY) was reported by Cantor Fitzgerald on Monday, November 20, 2023. The analyst firm set a ...

Get the latest Eli Lilly And Co (LLY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Find the latest Eli Lilly and Company (LLY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance

BofA Securities Raises Price Target on Eli Lilly to $700 From $600 on Obesity Drugs Lineup, Maintains Buy Rating Oct. 06: MT ANALYST RECOMMENDATIONS : Adobe, Apple, Dell, Eli Lilly, NatWest... Sep. 19: Argus Research Raises Price Target on Eli Lilly to $620 From $470, Maintains Buy Rating6 Okt 2023 ... The consensus from 20 financial analysts indicates an average analyst target price of USD 524.81 for Eli Lilly and Company's stock over the next ...View LLY revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $722.00: Low: $430.00: Average: $626.17: Current Price: $592.60: Yearly ...What is the target price for Eli Lilly (LLY) stock? A. The latest price target for Eli Lilly ( NYSE: LLY) was reported by Cantor Fitzgerald on Monday, November 20, 2023. The analyst firm set a ...Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.According to the issued ratings of 16 analysts in the last year, the consensus rating for Ally Financial stock is Hold based on the current 3 sell ratings, 8 hold ratings and 5 buy ratings for ALLY. The average twelve-month price prediction for Ally Financial is $29.80 with a high price target of $40.00 and a low price target of $20.00.Jul 21, 2023 · On July 21, 2023, Eli Lilly and Co (LLY) stock showed promising performance based on the information provided by CNN Money. The 23 analysts offering 12-month price forecasts for LLY had a median target of $490.00, with a high estimate of $565.00 and a low estimate of $300.00. In terms of financial performance, LLY reported earnings per share of ... SOPA Images/LightRocket via Getty Images. Eli Lilly stock (NYSE: LLY) currently trades at $459 per share, roughly 150% above its level in March 2021, and its valuation looks stretched now, in our ...

Jan 26, 2023 · Analysts remain bullish on the business. In December, several analysts updated their price targets for Eli Lilly. Even the lowest price target of $375 is still higher than where the stock trades ... Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.Apr 14, 2023 · Morgan Stanley analyst Terence Flynn maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of $445.00.The company’s shares closed yesterday at $375 ... Instagram:https://instagram. insider trading searchdoes forex.com accept us clientsdia etf stock pricelucd stock 9 jam yang lalu ... Eli Lilly Stock Prediction and Forecast [LLY] Eli Lilly price prediction was made for Monday, December 04, 2023 ▪️ Check the most recent LLY ...2 Nov 2022 ... He joins a spate of analysts lifting price targets on Lilly after the new drug's launch. At Truist Securities, analyst Robyn Karnauskas, who has ... best day trading brokersbest metatrader 4 brokers usa Target Corp () Stock Market info Recommendations: Buy or sell Target stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Target share forecasts, stock quote and buy / sell signals below.According to present data Target's TGT shares and potentially its market environment have been in bearish cycle last 12 months … best futures trading software Nov 13, 2023 · With 18 Buy and two Hold recommendations, Eli Lilly stock has a Strong Buy consensus rating.The average LLY stock price target of $645.44 implies 7.99% upside potential from current levels.Bottom ... Jul 2, 2023 · Eli Lilly is working on a molecule that might be better than Novo Nordisk's Ozempic. It already has another medicine on the market that could be better. But the stock's valuation may be a deal ... But Lilly's tirzepatide also targets a second hormone called GIP to improve the effects. ... LLY stock analysts also expect Alzheimer's drug donanemab to bring in $3 million this year before ...